Alt. Names,Gene Symbols
"AA536808; abelson murine leukemia viral oncogene homolog 2; Abelson tyrosine-protein kinase 2; Abelson-related gene protein; Abl2; Abll; ARG; MGC169395; tyrosine kinase ARG; Tyrosine-protein kinase ABL2; Tyrosine-protein kinase ARG; v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene); v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)",Abl2
ACAC; ACACA; ACACAD; ACC; ACC-alpha; ACC1; ACCA; Acetyl-CoA carboxylase 1; acetyl-CoA carboxylase alpha; acetyl-CoA carboxylase-alpha; acetyl-Coenzyme A carboxylase alpha; Biotin carboxylase,ACACA
"ADRB2; ADRB2R; ADRBR; adrenergic, beta-2-, receptor, surface; adrenoceptor beta 2; adrenoceptor beta 2 surface; B2AR; BAR; Beta-2 adrenergic receptor; Beta-2 adrenoceptor; Beta-2 adrenoreceptor; beta-2-Adrenergic Receptor; BETA2AR; catecholamine receptor",ADRB2
Annexin A1; Annexin I; Annexin-1; Anx; Anx-1; Anx-A1; Anx1; Anxa1; C430014K04Rik; Calpactin II; Calpactin-2; Chromobindin-9; lipocortin 1; Lipocortin I; Lpc; Lpc-1; Lpc1; p35; Phospholipase A2 inhibitory protein,Anxa1
"ABEC1; APOBEC-1; APOBEC1; apolipoprotein B mRNA editing enzyme catalytic subunit 1; apolipoprotein B mRNA editing enzyme complex-1; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1; Apolipoprotein B mRNA-editing enzyme 1; BEDP; C->U-editing enzyme APOBEC-1; CDAR1; HEPR; mRNA(cytosine(6666)) deaminase 1",APOBEC1
"ABEC1; Apobec1; apolipoprotein B editing complex 1; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1; Apolipoprotein B mRNA-editing enzyme 1; C->U-editing enzyme APOBEC-1; Cdar1; mRNA(cytosine(6666)) deaminase 1; OTTMUSP00000029041; OTTMUSP00000029042",Apobec1
Activating transcription factor 4; Atf-; Atf-4; Atf4; C/AT; C/ATF; C/EBP-related ATF; cAMP-dependent transcription factor ATF-4; cAMP-responsive element-binding protein 2; CREB; CREB-2; CREB2; Cyclic AMP-dependent transcription factor ATF-4; Cyclic AMP-responsive element-binding protein 2; MGC96460; Tax-responsive enhancer element-binding protein 67 homolog; TAXREB; TAXREB67; TaxREB67 homolog,Atf4
BAD; BBC2; BBC6; Bcl-2-binding component 6; Bcl-2-like protein 8; BCL-X/BCL-2 binding protein; Bcl-XL/Bcl-2-associated death promoter; Bcl2 antagonist of cell death; BCL2 associated agonist of cell death; BCL2-antagonist of cell death protein; Bcl2-associated agonist of cell death; BCL2-binding component 6; BCL2-binding protein; Bcl2-L-8; BCL2L8,BAD
"BCAR1; BCAR1 scaffold protein, Cas family member; BCAR1, Cas family scaffold protein; BCAR1, Cas family scaffolding protein; breast cancer anti-estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1; CAS1; CASS1; CRK-associated substrate; Crk-associated substrate p130Cas; CRKAS; FLJ12176; FLJ45059; p130cas",BCAR1
API4; Apoptosis inhibitor 4; Apoptosis inhibitor survivin; baculoviral IAP repeat containing 5; baculoviral IAP repeat-containing 5; Baculoviral IAP repeat-containing protein 5; BIRC5; EPR-1; IAP4; Survivin; survivin variant 3 alpha,BIRC5
"B lymphocyte kinase; B lymphoid tyrosine kinase; BLK; BLK nonreceptor tyrosine kinase; BLK proto-oncogene, Src family tyrosine kinase; MGC10442; MODY11; p55-Blk; Tyrosine-protein kinase Blk",BLK
AGM4; B cell adaptor containing SH2 domain; B cell linker; B cell linker protein; B-cell activation; B-cell adapter containing a SH2 domain protein; B-cell adapter containing a Src homology 2 domain protein; B-cell linker; B-cell linker protein; BASH; bca; BLNK; BLNK-S; Cytoplasmic adapter protein; LY57; MGC111051; SLP-65; SLP65; Src homology 2 domain-containing leukocyte protein of 65 kDa; Src homology [SH2] domain-containing leukocyte protein of 65 kD,BLNK
B-cell CLL/lymphoma 1; B-cell lymphoma 1 protein; BCL-1; BCL-1 oncogene; BCL1; CCND1; CycD1; cyclin D1; D11S287E; G1/S-specific cyclin D1; G1/S-specific cyclin-D1; PRAD1; PRAD1 oncogene; U21B31,CCND1
AI327039; bcl-; bcl-1; Ccnd1; cD1; CycD1; cyclin D1; Cyl-; Cyl-1; G1/S-specific cyclin-D1; OTTMUSP00000031858; PRAD1,Ccnd1
CCNE; CCNE1; cyclin E1; cyclin Es; cyclin Et; G1/S-specific cyclin-E1; pCCNE1,CCNE1
B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; B4; CD19; CD19 antigen; CD19 molecule; CVID3; Differentiation antigen CD19; MGC12802; T-cell surface antigen Leu-12,CD19
B-cell antigen receptor complex-associated protein alpha chain; Cd79; Cd79a; CD79A antigen (immunoglobulin-associated alpha); Ig alpha; Ig-; Ig-alpha; Iga; Igalpha; immunoglobulin-associated alpha; Ly-5; Ly-54; Ly5; Ly54; Mb-1; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein,Cd79a
CDC25A; CDC25A2; cell division cycle 25 homolog A (S. pombe); cell division cycle 25A; Dual specificity phosphatase Cdc25A; M-phase inducer phosphatase 1; MPIP1,CDC25A
Cdc25a; Cdc25m3; cell division cycle 25 homolog A (S. pombe); cell division cycle 25A; D9Ertd393; D9Ertd393e; Dual specificity phosphatase Cdc25A; M-phase inducer phosphatase 1; MPIP1,Cdc25a
A630093N05Rik; Cdk2; Cdkn2; Cell division protein kinase 2; Cyclin-dependent kinase 2,Cdk2
bb-1; Bgp; BGP-1; Bgp1; Bgpd; Biliary glycoprotein 1; Biliary glycoprotein D; C-CA; C-CAM; carcinoembryonic antigen 1; carcinoembryonic antigen 7; Carcinoembryonic antigen-related cell adhesion molecule 1; Cc1; CD66; CD66a; Cea; Cea-; Cea-1; Cea-7; CEA-related cell adhesion molecule 1; Cea1; Cea7; Ceacam1; CEAM1; hepatitis virus (MHV-4) susceptibility; hepatitis virus receptor; Hv-; Hv-2; Hv2; mCEA; mCEA1; MHV; Mhv-; Mhv-1; MHV-R; MHVR; MHVR1; mmCGM1; mmCGM1a; mmCGM2; Murine hepatitis virus receptor,Ceacam1
antigen CD66; BGP; BGP-1; BGP1; BGPI; Biliary glycoprotein 1; biliary glycoprotein adhesion molecule; carcinoembryonic antigen related cell adhesion molecule 1; Carcinoembryonic antigen-related cell adhesion molecule 1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); CD66a; CD66a antigen; CEA cell adhesion molecule 1; CEACAM1; CEAM1,CEACAM1
"C/ebp; C/EBP alpha; C/EBP-alpha; C/ebpalpha; CBF-A; CCAAT/enhancer binding protein (C/EBP), alpha; CCAAT/enhancer-binding protein alpha; Ceb; Cebp; Cebpa",Cebpa
"C/EBP beta; C/EBP-beta; CCAAT enhancer binding protein beta; CCAAT/enhancer binding protein (C/EBP), beta; CCAAT/enhancer-binding protein beta; CEBPB; CRP2; IL6DBP; interleukin 6-dependent DNA-binding protein; LAP; LIP; Liver activator protein; Liver-enriched inhibitory protein; liver-enriched transcriptional activator protein; MGC32080; NF-IL6; Nuclear factor NF-IL6; nuclear factor of interleukin 6; TCF-5; TCF5; Transcription factor 5; transcription factor C/EBP beta",CEBPB
"AA959946; Cfl1; Cof; COF1; cofilin 1, non-muscle; Cofilin, non-muscle isoform; Cofilin-1; n-c; n-cofilin",Cfl1
"C2TA; CIITA; CIITAIV; class II major histocompatibility complex transactivator; class II transactivator; class II, major histocompatibility complex, transactivator; MHC class II transactivator; MHC class II transactivator type I; MHC class II transactivator type III; MHC2TA; NLR family, acid domain containing; NLRA; nucleotide-binding oligomerization domain, leucine rich repeat and acid domain containing",CIITA
"Clathrin heavy chain 1; clathrin, heavy chain (Hc); clathrin, heavy polypeptide (Hc); CLH; Cltc",Cltc
cAMP response element binding protein 1; cAMP responsive element binding protein 1; cAMP-responsive element-binding protein 1; Creb; CREB-1; Creb1; Cyclic AMP-responsive element-binding protein 1; Y protein,Creb1
2310001E10Rik; 3526402H21Rik; AV083133; cAMP responsive element binding protein 1; cAMP-responsive element-binding protein 1; Cre; Creb; Creb-; CREB-1; Creb1; Cyclic AMP-responsive element-binding protein 1,Creb1
CBP; CREB binding protein; CREB-binding protein; Crebbp; Histone lysine acetyltransferase CREBBP; RSTS; RTS,Crebbp
cAMP responsive element moderator; cAMP responsive element modulator; cAMP-responsive element modulator; Crem; ICER; ICERI; Inducible cAMP early repressor,Crem
"Adapter molecule crk; avian sarcoma virus CT10 (v-crk) oncogene homolog; CRK; CRK proto-oncogene, adaptor protein; CRKII; p38; Proto-oncogene c-Crk; v-crk avian sarcoma virus CT10 oncogene homolog; v-crk sarcoma virus CT10 oncogene homolog (avian); v-crk sarcoma virus CT10 oncogene-like protein",CRK
"CRK like proto-oncogene, adaptor protein; Crk-like protein; CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; v-crk sarcoma virus CT10 oncogene homolog (avian)-like",CRKL
"alpha B-crystallin; Alpha(B)-crystallin; Alpha-crystallin B chain; Cry; Crya; Crya-2; Crya2; Cryab; crystallin, alpha 2; crystallin, alpha B; heat shock protein CryAB; heat shock protein HspB5; Hsp; HspB5; P23",Cryab
"C-Src kinase; c-src tyrosine kinase; C-terminal Src kinase; CSK; CSK, non-receptor tyrosine kinase; MGC117393; Protein-tyrosine kinase CYL; Tyrosine-protein kinase CSK",CSK
"DAB adaptor protein 1; Dab reelin signal transducer 1; Dab, reelin signal transducer, homolog 1; DAB1; DAB1, reelin adaptor protein; Disabled homolog 1; disabled homolog 1 (Drosophila); SCA37",DAB1
"Ceroid-lipofuscinosis neuronal protein 4; CLN4; CLN4B; CSP; Cysteine string protein; cysteine string protein alpha; DKFZp434N1429; DKFZp761N1221; DnaJ (Hsp40) homolog, subfamily C, member 5; DnaJ heat shock protein family (Hsp40) member C5; DnaJ homolog subfamily C member 5; DNAJC5; DNAJC5A; DNJC5; FLJ00118; FLJ13070; mir-941-2; mir-941-3; mir-941-4; mir-941-5; NCL",DNAJC5
Docking protein 2; Dok-R; Dok-related protein; Dok2; DokR; Downstream of tyrosine kinase 2; FRIP; IL-Four Receptor Interacting Protein; IL-four receptor-interacting protein; p56 dok-2; p56(dok-2),Dok2
"Collapsin response mediator protein 2; CRMP-2; Crmp2; dihydropyrimidinase-like 2; Dihydropyrimidinase-related protein 2; DPYL2; Dpysl2; DRP-2; TOAD-64; Turned on after division 64 kDa protein; turned on after division, 64 kDa protein",Dpysl2
dual specificity phosphatase 10; dual specificity phosphatase MKP-5; Dual specificity protein phosphatase 10; DUS10; DUSP10; MAP kinase phosphatase 5; Mitogen-activated protein kinase phosphatase 5; MKP-5; MKP5; serine/threonine specific protein phosphatase,DUSP10
dual specificity phosphatase 2; Dual specificity protein phosphatase 2; Dual specificity protein phosphatase PAC-1; DUS2; Dusp2; OTTMUSP00000017127; Pac-1; Pac1,Dusp2
dual specificity phosphatase 2; Dual specificity protein phosphatase 2; Dual specificity protein phosphatase PAC-1; dual-specificity phosphatase 2; DUS2; DUSP2; PAC-1; PAC1; serine/threonine specific protein phosphatase,DUSP2
candidate plasticity-related gene 21; Cpg21; dual specificity phosphatase 5; Dual specificity protein phosphatase 5; DUS5; Dusp5; MAP-kinase phosphatase (cpg21); MAP-kinase phosphatase CPG21,Dusp5
E2F transcription factor 1; E2F-1; E2f1; KIAA4009; mKIAA4009; OTTMUSP00000016974; RP23-109C16.5; Tg(Wnt1-cre)2Sor; Transcription factor E2F1,E2f1
"E2F transcription factor 5; E2F transcription factor 5, p130-binding; E2F-5; E2F5; Transcription factor E2F5",E2F5
Eef2; EF-2; EF2; Elongation factor 2; eukaryotic translation elongation factor 2; MGC98463,Eef2
CFND; CFNS; EFB1; EFL-3; EFL3; EFNB1; ELK ligand; ELK-L; EPH-related receptor tyrosine kinase ligand 2; Ephrin B1; Ephrin-B1; Ephrin-B1 C-terminal fragment; Ephrin-B1 CTF; Ephrin-B1 ICD; Ephrin-B1 intracellular domain; EPLG2; LERK-2; LERK2; ligand of eph-related kinase 2; MGC8782,EFNB1
A530045N19Rik; early growth response 1; Early growth response protein 1; egr; Egr-; EGR-1; Egr1; ETR10; ETR103; Krox; Krox-; Krox-1; Krox-24; Krox-24 nuclear protein; Krox24; Nerve growth factor-induced protein A; NGF; NGF1; NGF1-A; NGFI-A; NGFIA; OTTMUSP00000023149; TIS8; Transcription factor Zif268; Zen; Zenk; Zfp-; Zfp-6; Zif26; Zif268; Zinc finger protein Krox-24,Egr1
E2AK1; EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase 1; Eukaryotic translation initiation factor 2-alpha kinase 1; HCR; heme regulated initiation factor 2 alpha kinase; heme sensitive initiation factor 2a kinase; Heme-controlled repressor; Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase; Heme-regulated inhibitor; heme-regulated initiation factor 2-alpha kinase; heme-regulated repressor; Hemin-sensitive initiation factor 2-alpha kinase; hHRI; HRI; KIAA1369; LEMSPAD,EIF2AK1
"CACH; CLE; EI2BE; EIF-2B; eIF-2B GDP-GTP exchange factor subunit epsilon; eIF2B-epsilon; EIF2B5; EIF2BE; EIF2Bepsilon; eukaryotic translation initiation factor 2B subunit epsilon; eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa; LVWM; Translation initiation factor eIF-2B subunit epsilon",EIF2B5
"eIF-2-alpha; eIF-2A; eIF-2alpha; eIF2-alpha; Eif2a; Eif2s1; Eukaryotic translation initiation factor 2 subunit 1; Eukaryotic translation initiation factor 2 subunit alpha; eukaryotic translation initiation factor 2, subunit 1 alpha; MGC93488",Eif2s1
eIF-5; Eif5; eukaryotic initiation factor 5 (eIF-5); Eukaryotic translation initiation factor 5; IF5,Eif5
"Elk-; Elk-1; Elk1; ELK1, member of ETS oncogene family; ETS domain-containing protein Elk-1; OTTMUSP00000018693",Elk1
"avian erythroblastosis oncogene B 2; c-erbB; c-erbB-2; c-erbB2; c-ne; c-neu; CD340; erb-b2 receptor tyrosine kinase 2; ErbB-; Erbb-2; Erbb2; HER; HER-; HER-2; HER2; Kiaa3023; l11Ju; l11Jus8; mKIAA3023; Neu; Neu oncogene; OTTMUSP00000002540; p185erbB2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; Receptor tyrosine-protein kinase erbB-2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",Erbb2
Erf; Est2 repressor factor; ETS domain-containing transcription factor ERF; Ets2 repressor factor,Erf
"Caspase-like protein ESPL1; ESP1; ESPL1; extra spindle pole bodies 1, separase; extra spindle pole bodies homolog 1; extra spindle pole bodies homolog 1 (S. cerevisiae); extra spindle pole bodies like 1, separase; extra spindle poles like 1; Extra spindle poles-like 1 protein; FLJ46492; KIAA0165; SEPA; Separase; Separin; separin, cysteine protease",ESPL1
FADD; Fas (TNFRSF6)-associated via death domain; Fas associated via death domain; FAS-associated death domain protein; FAS-associating death domain-containing protein; Fas-associating protein with death domain; GIG3; Growth-inhibiting gene 3 protein; Mediator of receptor induced toxicity; mediator of receptor-induced toxicity; MGC8528; MORT1; Protein FADD,FADD
"AI528646; CD32; F630109E10Rik; Fc gamma receptor IIB; Fc gamma RIIB; Fc receptor, IgG, low affinity IIb; Fc-gamma RII; Fc-gamma-RII; Fc-gamma-RIIB; Fc[g]; Fc[g]RII; Fcg; Fcgamm; FcgammaRIIB; Fcgr; Fcgr2; Fcgr2a; Fcgr2b; FcgRII; Fcr-; Fcr-2; Fcr-3; FcRII; IgG Fc receptor II beta; Low affinity immunoglobulin gamma Fc region receptor II; low affinity immunoglobulin gamma Fc region receptor II-b; Ly-1; Ly-17; Ly-m2; Ly-m20; LyM-; LyM-1; Lymphocyte antigen 17; OTTMUSP00000024374; OTTMUSP00000024375",Fcgr2
"bacteria-expressed kinase; BBDS; BEK; BEK fibroblast growth factor receptor; BFR-1; CD332; CEK3; CFD1; ECT1; FGF receptor; FGFR-2; FGFR2; Fibroblast growth factor receptor 2; FLJ98662; JWS; K-sam; Keratinocyte growth factor receptor; KGFR; KSAM; protein tyrosine kinase, receptor like 14; soluble FGFR4 variant 4; TK14; TK25",FGFR2
CD334; CTLA-2-beta protein; Fgfr-; FGFR-4; Fgfr4; Fibroblast growth factor receptor 4; fibroblast growth factor receptor 4 16 minus form; Mpk-11; Protein-tyrosine kinase receptor MPK-11,Fgfr4
"c-fgr; c-fgr protooncogene; c-src-2 proto-oncogene; c-src2; feline Gardner-Rasheed sarcoma viral oncogene homolog; FGR; FGR proto-oncogene, Src family tyrosine kinase; FLJ43153; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog; MGC75096; p55-c-fgr protein; p55-Fgr; p55c-fgr; p58-Fgr; p58c-fgr; Proto-oncogene c-Fgr; proto-oncogene tyrosine-protein kinase FGR; SRC2; Tyrosine-protein kinase Fgr; v-fgr feline Gardner-Rasheed sarcoma viral oncogene homolog",FGR
FLT; FLT-1; FLT1; fms related receptor tyrosine kinase 1; fms related tyrosine kinase 1; Fms-like tyrosine kinase 1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor); FRT; Tyrosine-protein kinase FRT; Tyrosine-protein kinase receptor FLT; Vascular endothelial growth factor receptor 1; Vascular permeability factor receptor; VEGFR-1; VEGFR1; VGFR1,FLT1
AI323757; Embryonic receptor kinase 2; Emrk2; Flt; Flt-; FLT-1; Flt1; Fms-like tyrosine kinase 1; OTTMUSP00000023727; sFl; sFlt1; Tyrosine-protein kinase receptor FLT; Vascular endothelial growth factor receptor 1; vascular endothelial growth factor receptor-1; vascular permeability factor receptor; VEGF; VEGFR; VEGFR-1; VEGFR1; VGFR1,Flt1
"activator protein 1; AP-1; C-FOS; cellular oncogene c-fos; Cellular oncogene fos; cfos; FBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS); FBJ murine osteosarcoma viral oncogene homolog; FOS; Fos proto-oncogene, AP-1 trancription factor subunit; Fos proto-oncogene, AP-1 transcription factor subunit; G0/G1 switch regulatory protein 7; G0S7; p55; Protein c-Fos; Proto-oncogene c-Fos; v-fos FBJ murine osteosarcoma viral oncogene homolog",FOS
Afx; Afxh; AI876417; FKH; Fkhr; Fkhr1; forkhead box O1; forkhead box O1a; Forkhead box protein O1; Forkhead box protein O1A; Forkhead in rhabdomyosarcoma; forkhead protein 1; Fox; Foxo1; Foxo1a; OTTMUSP00000023486,Foxo1
1110048B16Rik; 2010203A17Rik; C76856; FKHR; Fkhr2; FKHRL1; forkhead box O3; Forkhead box O3a; Forkhead box protein O3; Forkhead protein FKHR2; Fox; Foxo3; Foxo3a; OTTMUSP00000022929; OTTMUSP00000022930,Foxo3
Afx; Afx1; Afxh; Fkhr3; Fork head domain transcription factor AFX1; forkhead box O4; Forkhead box protein O4; forkhead protein; Fox; Foxo4; MGC117660; Mll; Mllt7; myeloid/lymphoid or mixed lineage-leukemia translocation to 7 homolog,Foxo4
AI448320; AW552119; Fyn; Fyn proto-oncogene; MGC115870; p59-Fyn; Proto-oncogene c-Fyn; proto-oncogene tyrosine-protein kinase Fyn; Src Kinase p59; Tyrosine-protein kinase Fyn,Fyn
AI463667; D130058I17Rik; Gab2; Grb2 associated binder 2; GRB2-associated binder 2; GRB2-associated-binding protein 2; Growth factor receptor bound protein 2-associated protein 2; p97; PH domain-containing adaptor molecule p97,Gab2
"alpha 1 connexin; AU042049; AW546267; Cnx4; Cnx43; conne; connexin 43; connexin k1; Connexin-43; connexin43; Cx43; Cx43al; Cx43alpha1; CXA1; Cxn-43; Cxnk1; Gap junction 43 kDa heart protein; Gap junction alpha-1 protein; gap junction membrane channel protein alpha 1; gap junction protein, alpha 1; Gja-; Gja-1; Gja1; Npm1",Gja1
"2010305F15Rik; AA536815; AI115529; AI314170; AI842738; G-gamma 12; GBG12; Gng12; guanine nucleotide binding protein (G protein), gamma 12; Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12; OTTMUSP00000026466; OTTMUSP00000026467; OTTMUSP00000026468; OTTMUSP00000026469; OTTMUSP00000026470; OTTMUSP00000026471; OTTMUSP00000026472",Gng12
"FLJ31352; FLJ34695; G protein subunit gamma 12; G-gamma 12; G-protein gamma-12 subunit; GBG12; GNG12; guanine nucleotide binding protein (G protein), gamma 12; Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12",GNG12
Grb-10; GRB-IR; GRB10; GRB10 adapter protein; GRB10 adaptor protein; GRBIR; growth factor receptor bound protein 10; Growth factor receptor-bound protein 10; Insulin receptor-binding protein Grb-IR; IRBP; KIAA0207; maternally expressed gene 1; MEG1; RSS,GRB10
abundant SRC homology; Adapter protein GRB2; ASH; EGFRBP-GRB2; epidermal growth factor receptor-binding protein GRB2; epididymis secretory sperm binding protein; GRB2; Grb3-3; growth factor receptor bound protein 2; Growth factor receptor-bound protein 2; growth factor receptor-bound protein 3; HT027; MST084; MSTP084; NCKAP2; Protein Ash; SH2/SH3 adapter GRB2,GRB2
AA408164; Adapter protein GRB2; Ash; Grb2; growth factor receptor bound protein 2; Growth factor receptor-bound protein 2; OTTMUSP00000003660; OTTMUSP00000003661; RP23-28I4.1; SH2/SH3 adapter GRB2,Grb2
"AMPA-selective glutamate receptor 2; GluA2; GluR-2; GluR-B; GluR-K2; GLUR2; GLURB; glutamate ionotropic receptor AMPA type subunit 2; Glutamate receptor 2; Glutamate receptor ionotropic, AMPA 2; glutamate receptor, ionotropic, AMPA 2; GRIA2; HBGR2; NEDLIB",GRIA2
"EPND; FESD; GluN2A; Glutamate [NMDA] receptor subunit epsilon-1; glutamate ionotropic receptor NMDA type subunit 2A; Glutamate receptor ionotropic, NMDA 2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; GRIN2A; hNR2A; LKS; N-methyl D-aspartate receptor subtype 2A; N-methyl-D-aspartate receptor channel, subunit epsilon-1; N-methyl-D-aspartate receptor subunit 2A; NMDA receptor subtype 2A; NMDAR2A; NMDE1; NR2A",GRIN2A
"Glu; GluN2A; GluRepsilon1; Glutamate [NMDA] receptor subunit epsilon-1; Glutamate receptor ionotropic, NMDA 2A; glutamate receptor, ionotropic, NMDA2A (epsilon 1); Grin2a; N-methyl D-aspartate receptor subtype 2A; NMD; NMDAR2A; NMDE1; NR2A; OTTMUSP00000017426",Grin2a
"Adrbk1; adrenergic receptor kinase, beta 1; adrenergic, beta, receptor kinase 1; ARBK1; BARK1; Beta-adrenergic receptor kinase 1; beta-adrenergic receptor kinase 1 beta ARK1; Beta-ARK-1; G-protein-coupled receptor kinase 2; GRK-2; Grk2",Grk2
7330414F15Rik; 8430431H08Rik; C86142; glycogen synthase kinase 3 beta; Glycogen synthase kinase-3 beta; GSK; GSK-; GSK-3; GSK-3 beta; GSK-3be; GSK-3beta; GSK3; Gsk3b; GSK3beta; OTTMUSP00000017445; Serine/threonine-protein kinase GSK3B,Gsk3b
"HCK; HCK proto-oncogene, Src family tyrosine kinase; Hematopoietic cell kinase; Hemopoietic cell kinase; JTK9; p59-HCK/p60-HCK; p59Hck; p61Hck; Tyrosine-protein kinase HCK",HCK
"DKFZp686H12203; GON-10; HD1; HDAC 1; HDAC1; Histone deacetylase 1; KDAC1; reduced potassium dependency, yeast homolog-like 1; RPD3; RPD3L1",HDAC1
AI426555; HD5; Hdac4; Hdac5; histone deacetylase 4; Histone deacetylase 5; Histone deacetylase mHDA1; mHDA; mHDA1; mKIAA0600; OTTMUSP00000002428,Hdac5
AA138857; D16Ertd95; D16Ertd95e; Gm15797; Hira; histone cell cycle regulation defective homolog A; histone cell cycle regulation defective homolog A (S. cerevisiae); histone cell cycle regulator; N28177; Protein HIRA; TUP1-like enhancer of split gene 1; TUP1-like enhancer of split protein 1; Tupl; Tuple1,Hira
3-hydroxy-3-methylglutaryl CoA reductase (NADPH); 3-hydroxy-3-methylglutaryl-CoA reductase; 3-hydroxy-3-methylglutaryl-coenzyme A reductase; HMDH; HMG-CoA reductase; HMGCR; hydroxymethylglutaryl-CoA reductase; LDLCQ3,HMGCR
"EL52; epididymis luminal secretory protein 52; epididymis secretory sperm binding protein Li 65p; FLJ31884; Heat shock 86 kDa; heat shock 90kD protein 1, alpha; heat shock 90kD protein 1, alpha-like 4; heat shock 90kD protein, alpha-like 4; heat shock 90kDa protein 1, alpha; heat shock protein 90 alpha family class A member 1; heat shock protein 90kDa alpha (cytosolic), class A member 1; heat shock protein 90kDa alpha family class A member 1; Heat shock protein HSP 90-alpha; HEL-S-65p; HS90A; HSP 86; Hsp103; HSP86; Hsp89; HSP89A; Hsp90; HSP90A; HSP90AA1; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; LAP-2; LAP2; Lipopolysaccharide-associated protein 2; LPS-associated protein 2; Renal carcinoma antigen NY-REN-38",HSP90AA1
"27kDa; Growth-related 25 kDa protein; Heat shock 25 kDa protein; Heat shock 27 kDa protein; heat shock 27kDa protein 1; heat shock protein 1; Heat shock protein beta-1; heat shock protein, 25 kDa; Hsp; HSP 25; HSP 27; Hsp25; Hsp27; HspB1; OTTMUSP00000028918; p25; truncated hsp25",Hspb1
"HD; HD protein; HTT; Huntingtin; Huntingtin, myristoylated N-terminal fragment; Huntington disease protein; IT15; LOMARS",HTT
Hd; HD protein homolog; Hdh; Htt; Huntingtin; huntingtin (Huntington disease); Huntington disease gene homolog; Huntington disease protein homolog,Htt
IGF-I receptor; Igf1r; IGFIRC; Insulin-like growth factor 1 receptor; Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain; Insulin-like growth factor I receptor; JTK13,Igf1r
"I-kappa-B kinase epsilon; IKBKE; IKK-E; IKK-epsilon; IKK-i; IKK-related kinase epsilon; IKKE; IKKI; Inducible I kappa-B kinase; inducible IkappaB kinase; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon; inhibitor of nuclear factor kappa B kinase subunit epsilon; Inhibitor of nuclear factor kappa-B kinase subunit epsilon; KIAA0151; MGC125294; MGC125295; MGC125297",IKBKE
"CD130; CD130 antigen; CDw130; gp130; gp130 of the rheumatoid arthritis antigenic peptide-bearing soluble form; gp130 transducer chain; gp130, oncostatin M receptor; GP130-RAPS; HIES4; IL-6 receptor subunit beta; IL-6R subunit beta; IL-6R-beta; IL-6RB; IL6R-beta; IL6RB; IL6ST; IL6ST nirs variant 3; interleukin 6 signal transducer; interleukin 6 signal transducer (gp130, oncostatin M receptor); interleukin receptor beta chain; Interleukin-6 receptor subunit beta; Interleukin-6 signal transducer; Membrane glycoprotein 130; membrane glycoprotein gp130; oncostatin M receptor; Oncostatin-M receptor subunit alpha; sGP130",IL6ST
5133400A03Rik; AA389424; BB405851; CD130; D13Ertd699; D13Ertd699e; gp13; gp130; IL-6 receptor subunit beta; IL-6R subunit beta; IL-6R-beta; IL-6RB; IL6RB; Il6st; interleukin 6 signal transducer; Interleukin-6 receptor subunit beta; Interleukin-6 signal transducer; Membrane glycoprotein 130; Oncostatin-M receptor subunit alpha,Il6st
"alpha 3 subunit of VLA-3 receptor; antigen CD49C; antigen identified by monoclonal antibody J143; CD49 antigen-like family member C; CD49C; FLJ34631; FLJ34704; FRP-2; Galactoprotein B3; GAP-B3; GAPB3; ILNEB; integrin alpha 3; Integrin alpha-3; Integrin alpha-3 heavy chain; Integrin alpha-3 light chain; integrin subunit alpha 3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); ITA3; ITGA3; MSK18; testicular tissue protein Li 96; testicular tissue protein Li 98; VCA-2; very late activation protein 3 receptor, alpha-3 subunit; VL3A; VLA-3 subunit alpha; VLA3a",ITGA3
AA960307; BAP0; BAP004; C130039L05Rik; JAK-1; Jak1; Janus kinase 1; MGC37919; OTTMUSP00000008566; Tyrosine-protein kinase JAK1,Jak1
JAK-2; Jak2; Janus kinase 2; Janus kinase 2 (a protein tyrosine kinase); Tyrosine-protein kinase JAK2,Jak2
fae; JAK-3; Jak3; Janus kinase 3; OTTMUSP00000023247; OTTMUSP00000023248; OTTMUSP00000023249; Tyrosine-protein kinase JAK3; wil,Jak3
c-Jun dimerization protein 2; Jdp2; Jun dimerization protein 2; Jundm; Jundm2; Jundp2; TIF,Jdp2
EG5; HKSP; KIF11; kinesin family member 11; kinesin-like 1; Kinesin-like protein 1; Kinesin-like protein KIF11; Kinesin-like spindle protein HKSP; Kinesin-related motor protein Eg5; KNSL1; MCLMR; thyroid receptor interacting protein 5; Thyroid receptor-interacting protein 5; TR-interacting protein 5; TRIP-5; TRIP5,KIF11
Eg5; Kif; Kif11; Kif8; Kifl1; kinesin 11; kinesin family member 11; kinesin-like 1; Kinesin-like protein KIF11; Kinesin-related motor protein Eg5; Knsl1,Kif11
"AA960620; AL022697; AU019895; Car; Card2; CK-8; cytokeratin 8; Cytokeratin endo A; Cytokeratin-8; EndoA; K2C8; K8; keratin 8; keratin complex 2, basic, gene 8; Keratin, type II cytoskeletal 8; Keratin-8; Krt-2.; Krt-2.8; Krt2-; Krt2-8; Krt8; MGC118110; Type-II keratin Kb8",Krt8
76 kDa tyrosine phosphoprotein; LCP2; Lymphocyte cytosolic protein 2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa); SH2 domain-containing leukocyte protein of 76 kDa; SH2 domain-containing leukocyte protein of 76kD; SLP-76; SLP-76 tyrosine phosphoprotein; SLP76,LCP2
AI323664; BB161688; Lcp2; Lymphocyte cytosolic protein 2; m1Kho; m1Khoe; RP23-216O18.1; SH2 domain-containing leukocyte protein of 76 kDa; SLP; SLP-76; SLP-76 tyrosine phosphoprotein; SLP76; twm,Lcp2
"AL033288; DNA ligase 1; DNA ligase I; DNLI1; Lig-1; Lig1; ligase I, DNA, ATP-dependent; LigI; Polydeoxyribonucleotide synthase [ATP] 1",Lig1
DKFZp686I2148; MAP-2; MAP2; MAP2A; MAP2B; MAP2C; microtubule associated protein 2; Microtubule-associated protein 2; MTAP2,MAP2
"Dual specificity mitogen-activated protein kinase kinase 1; ERK activator kinase 1; MAP kinase kinase 1; Map2k1; MAPK/ERK kinase 1; MAPKK 1; MAPKK1; MEK 1; Mek1; MEKK1; mitogen activated protein kinase kinase 1; mitogen-activated protein kinase kinase 1; MP2K1; OTTMUSP00000018355; Prkm; Prkmk1; protein kinase, mitogen activated, kinase 1, p45",Map2k1
"C-JUN N-terminal kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 4; JNK kinase 1; JNK-activating kinase 1; JNKK; JNKK 1; Jnkk1; MAP kinase kinase 4; Map2k4; MAPK/ERK kinase 4; MAPKK 4; MEK 4; MEK4; mitogen activated protein kinase kinase 4, variant 1; mitogen-activated protein kinase kinase 4; MKK4; MP2K4; OTTMUSP00000006102; Prkmk4; SAPK/ERK kinase 1; SAPK/Erk/kinase 1; Sek; SEK1; Ser; Serk1; Skk1",Map2k4
"dual specificity mitogen-activated protein kinase kinase 6; Map2k6; MGC93287; Mitogen-activated protein kinase kinase 6; Mitogen-activated protein kinase kinase 6, isoform CRA_a; Mkk6",Map2k6
2610017K16Rik; M3K11; Map3k11; mitogen activated protein kinase kinase kinase 11; Mitogen-activated protein kinase kinase kinase 11; Mixed lineage kinase 3; Mlk; Mlk3; PTK1; SPRK,Map3k11
"ERK; ERK-1; Erk1; ERT2; Esrk1; Extracellular signal-regulated kinase 1; extracellular-signal-regulated kinase 1; Insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 3; MAP kinase isoform p44; MAPK 1; MAPK 3; Mapk3; Microtubule-associated protein 2 kinase; mitogen activated kinase 3; mitogen activated protein kinase 3; mitogen-activated 3 (MAP kinase 3); Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 3; MK03; MNK1; p44; p44-ERK1; p44-MAPK; p44erk1; p44mapk; Prkm3; Protein kinase mitogen activated 3 (extracellular-signal-regulated kinase 1 ERK1); protein kinase, mitogen activated 3 (extracellular-signal-regulated kinase 1, ERK1)",Mapk3
b2b2346C; b2b2346Clo; Big MAP kinase 1; BMK-1; Bmk1; ERK; ERK-5; Erk5; Erk5-; Erk5-T; extracellular signal regulated kinase 5; Extracellular signal-regulated kinase 5; MAP kinase 7; MAPK 7; Mapk7; mitogen activated protein kinase 7; mitogen-activated kinase 7; Mitogen-activated protein kinase 7; MK07; OTTMUSP00000006027; PRKM7,Mapk7
"AI851083; c-Jun N-terminal kinase 2; JNK; JNK/SAPK alpha; Jnk2; Jun kinase; MAP kinase 9; MAPK 9; Mapk9; mitogen activated protein kinase 9; Mitogen-activated protein kinase 9; MK09; OTTMUSP00000005725; OTTMUSP00000005726; p54aSAPK; Prk; Prkm9; protein kinase, mitogen-activated 9; Stress-activated protein kinase JNK2",Mapk9
1700007J15Rik; AA415488; Double minute 2 protein; E3 ubiquitin-protein ligase Mdm2; Mdm-2; Mdm2; Oncoprotein Mdm2; OTTMUSP00000022916; p53-binding protein Mdm2; RING-type E3 ubiquitin transferase Mdm2; transformed mouse 3T3 cell double minute 2,Mdm2
"ADMCKD; ADMCKD1; Breast carcinoma-associated antigen DF3; CA 15-3; Cancer antigen 15-3; Carcinoma-associated mucin; CD227; DF3 antigen; EMA; Episialin; H23 antigen; H23AG; KL-6; Krebs von den Lungen-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1; MUC1-alpha; MUC1-beta; MUC1-CT; MUC1-NT; MUC1/ZD; mucin 1, cell surface associated; mucin 1, transmembrane; Mucin-1; Mucin-1 subunit alpha; Mucin-1 subunit beta; Peanut-reactive urinary mucin; PEM; PEMT; Polymorphic epithelial mucin; PUM; tumor associated epithelial mucin; Tumor-associated epithelial membrane antigen; Tumor-associated mucin",MUC1
"ML12B; MLC-2; MLC-2A; MLC-B; MLC20; MRLC2; MYL12B; MYLC2B; myosin light chain 12B; Myosin regulatory light chain 12B; myosin regulatory light chain 2; Myosin regulatory light chain 2-B, smooth muscle isoform; Myosin regulatory light chain 20 kDa; Myosin regulatory light chain MRLC2; myosin, light chain 12B, regulatory; SHUJUN-1",MYL12B
AI451400; NCF-4; Ncf4; Neutrophil cytosol factor 4; neutrophil cytosolic factor 4; neutrophil NADPH oxidase factor 4; p40-phox; p40p; p40phox,Ncf4
"160 kDa neurofilament protein; NEF3; NEFM; Neurofilament 3; Neurofilament M; neurofilament medium; Neurofilament medium polypeptide; Neurofilament triplet M protein; neurofilament, medium polypeptide; neurofilament, medium polypeptide 150kDa; neurofilament-3 (150 kD medium); NF-M; NFM",NEFM
NEK7; Never in mitosis A-related kinase 7; NIMA (never in mitosis gene a)-related kinase 7; NIMA related kinase 7; NimA-related protein kinase 7; Serine/threonine-protein kinase Nek7,NEK7
"I-kappa-B-beta; IkappaBbeta; IkB-B; IkB-beta; IKBB; NF-kappa-B inhibitor beta; NF-kappa-BIB; NFKB inhibitor beta; NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; Thyroid receptor-interacting protein 9; TR-interacting protein 9; TRIP-9; TRIP9",NFKBIB
AI893888; ANP-A; ANPA; ANPR-A; ANPRA; Atrial natriuretic peptide receptor 1; Atrial natriuretic peptide receptor type A; GC-; GC-A; Guanylate cyclase A; guanylyl cyclase-A; MGC117511; natriuretic peptide receptor 1; Nppa receptor; NPR-A; Npr1; Npra; Pndr,Npr1
AMDM; ANP-B; ANPb; ANPR-B; ANPRB; atrial natriuretic peptide B-type receptor; Atrial natriuretic peptide receptor 2; Atrial natriuretic peptide receptor type B; ECDM; GC-B; GCB; guanylate cyclase 2B; Guanylate cyclase B; GUC2B; GUCY2B; natriuretic peptide receptor 2; natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B); NPR-B; NPR2; NPRB; NPRBi; SNSK,NPR2
ANP-B; ANPB; ANPR-B; ANPRB; atrial natriuretic peptide B-type receptor; Atrial natriuretic peptide receptor 2; atrial natriuretic peptide receptor B; Atrial natriuretic peptide receptor type B; GC-B; Guanylate cyclase B; natriuretic peptide receptor 2; natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B); natriuretic peptide receptor-B; NPR-B; Npr2,Npr2
"GCCR; GCR; GCRST; glucocorticoid nuclear receptor variant 1; Glucocorticoid receptor; GR; GRL; NR3C1; Nuclear receptor subfamily 3 group C member 1; nuclear receptor subfamily 3 group C member 1 variant hGR-B(54); nuclear receptor subfamily 3 group C member 1 variant hGR-B(77); nuclear receptor subfamily 3 group C member 1 variant hGR-B(93); nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",NR3C1
O linked N-acetylglucosamine transferase; O-GlcNAc transferase subunit p110; O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase); O-linked N-acetylglucosamine transferase 110 kDa subunit; Ogt; OGT1; UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit; UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase,Ogt
"D-OR-1; delta opioid receptor 1; Delta-type opioid receptor; DOP; DOR; DOR-1; DOR1; opioid receptor delta 1; opioid receptor, delta 1; OPRD; OPRD1",OPRD1
"CGI-PDE B; CGIP1; CGIPDE1; cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B; Cyclic GMP-inhibited phosphodiesterase B; cyclic nucleotide phosphodiesterase; HcGIP1; PDE3B; phosphodiesterase 3B; phosphodiesterase 3B, cGMP-inhibited",PDE3B
"9830102A01Rik; AI847709; CGI-PDE B; CGIPDE1; cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B; Cyclic GMP-inhibited phosphodiesterase B; OTTMUSP00000031097; Pde3b; phosphodiesterase 3B, cGMP-inhibited",Pde3b
"CGB-PDE; cGMP-binding cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase; cGMP-binding cGMP-specific phosphodiesterase; cGMP-specific 3',5'-cyclic phosphodiesterase; cGMP-specific phosphodiesterase PDE5A2; cGMP-specific phosphodiesterase type 5A; CN5A; PDE5; PDE5A; PDE5A1; phosphodiesterase 5A; phosphodiesterase 5A, cGMP-specific; phosphodiesterase isozyme 5",PDE5A
"Alpha platelet-derived growth factor receptor; Alpha-type platelet-derived growth factor receptor; CD140; CD140 antigen-like family member A; CD140A; CD140a antigen; MGC74795; PDGF-R-alpha; PDGFR alpha; PDGFR-2; PDGFR-alpha; PDGFR2; PDGFRA; PDGFRalpha; PGFRA; platelet derived growth factor receptor alpha; Platelet-derived growth factor alpha receptor; Platelet-derived growth factor receptor 2; Platelet-derived growth factor receptor alpha; platelet-derived growth factor receptor, alpha polypeptide; rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein; RHEPDGFRA",PDGFRA
"ODPA; OTTMUSP00000020974; Pdha; Pdha-1; Pdha1; PDHE1-A type I; pyruvate dehydrogenase E1 alpha 1; Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial; pyruvate dehydrogenase E1alpha subunit",Pdha1
"6-phosphofructo-2-kinase; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2; 6PF-2-K/Fru-2,6-P2ase 2; 6PF-2-K/Fru-2,6-P2ase heart-type isozyme; DKFZp781D2217; F262; Fructose-2,6-bisphosphatase; fructose-2,6-bisphosphatase, cardiac isozyme; MGC138308; MGC138310; PFK-2/FBPase-2; PFK/FBPase 2; PFKFB, cardiac; PFKFB2",PFKFB2
NR3C3; Nuclear receptor subfamily 3 group C member 3; PGR; PR; PRGR; Progesterone receptor,PGR
"cPL; Cpla2; cPLA2-alpha; cPLA2alpha; Cytosolic phospholipase A2; Cytosolic phospholipase A2 (CPLA2); cytosolic PLA2; Lysophospholipase; OTTMUSP00000017675; PA24A; Phosphatidylcholine 2-acylhydrolase; Phospholipase A2; Phospholipase A2 group IVA; phospholipase A2, group 4; phospholipase A2, group IVA (cytosolic, calcium-dependent); Pla; Pla2g4; Pla2g4a; Type IV PLA2",Pla2g4a
"1-phosphatidyl-D-myo-inositol-4,5-bisphosphate; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1; 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1; 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1; inositoltrisphosphohydrolase; monophosphatidylinositol phosphodiesterase; NCKAP3; phosphatidylinositol phospholipase C; phosphoinositidase C; phosphoinositide phospholipase C; Phosphoinositide phospholipase C-gamma-1; phospholipase C gamma 1; phospholipase C, gamma 1; phospholipase C, gamma 1 (formerly subtype 148); phospholipase C-148; Phospholipase C-gamma-1; Phospholipase C-II; PLC-148; PLC-gamma-1; PLC-II; PLC1; PLC148; PLCG1; PLCgamma1; triphosphoinositide phosphodiesterase",PLCG1
"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2; 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2; APLAID; FCAS3; Phosphoinositide phospholipase C-gamma-2; phospholipase C gamma 2; phospholipase C, gamma 2 (phosphatidylinositol-specific); phospholipase C, gamma 2 (phosphatidylyinositol-specific); Phospholipase C-gamma-2; Phospholipase C-IV; PLC-gamma-2; PLC-IV; PLCG2",PLCG2
"DNA-directed RNA polymerase II largest subunit, RNA polymerase II 220 kd subunit; DNA-directed RNA polymerase II subunit A; DNA-directed RNA polymerase II subunit RPB1; DNA-directed RNA polymerase III largest subunit; hRPB220; hsRPB1; MGC75453; NEDHIB; POL II; POLR2; POLR2A; POLRA; polymerase (RNA) II (DNA directed) polypeptide A, 220kDa; polymerase (RNA) II subunit A; RNA polymerase II subunit A; RNA polymerase II subunit B1; RNA-directed RNA polymerase II subunit RPB1; RNAPII; RPB1; RPBh1; RpIILS; RPO2; RPOL2",POLR2A
220kD; 220kDa; DNA-directed RNA polymerase II A; DNA-directed RNA polymerase II subunit A; DNA-directed RNA polymerase II subunit RPB1; DNA-directed RNA polymerase III largest subunit; POL II; Polr2a; polymerase (RNA) II (DNA directed) polypeptide A; RNA polymerase II 1; RNA polymerase II subunit B1; RNAPII; Rpb1; Rpii215; Rpo; Rpo2-1,Polr2a
CIMT1; GLM1; NR1C3; Nuclear receptor subfamily 1 group C member 3; peroxisome proliferative activated receptor gamma; peroxisome proliferator activated receptor gamma; peroxisome proliferator-activated nuclear receptor gamma variant 1; Peroxisome proliferator-activated receptor gamma; peroxisome proliferator-activated receptor gamma 1; peroxisome proliferator-activated receptor-gamma 5; peroxisome proliferator-activated receptor-gamma splicing; PPAR gamma; PPAR-gamma; PPARG; PPARG1; PPARG2; PPARG5; PPARgamma,PPARG
"epididymis secretory sperm binding protein Li 80p; HEL-S-80p; MGC3672; MP; myosin phosphatase; NSLH2; PP-1B; PP1B; PP1beta; PP1c; PPP1beta; PPP1CB; PPP1CD; protein phosphatase 1 catalytic subunit beta; protein phosphatase 1, catalytic subunit, beta isoform; protein phosphatase 1, catalytic subunit, beta isozyme; protein phosphatase 1, catalytic subunit, delta isoform; protein phosphatase 1-beta; protein phosphatase 1-delta; serine/threonine protein phosphatase PP1-beta catalytic subunit; Serine/threonine-protein phosphatase PP1-beta catalytic subunit",PPP1CB
"GUBS; M130; MBS; MGC133042; myosin binding subunit; Myosin phosphatase target subunit 1; myosin phosphatase, target subunit 1; Myosin phosphatase-targeting subunit 1; MYPT1; PPP1R12A; Protein phosphatase 1 regulatory subunit 12A; protein phosphatase 1, regulatory (inhibitor) subunit 12A; Protein phosphatase myosin-binding subunit",PPP1R12A
"1200015F06Rik; 5730577I22Rik; AA792106; AV099298; D10Ertd625; D10Ertd625e; MGC159084; Myosin phosphatase target subunit 1; myosin phosphatase, target subunit 1; Myosin phosphatase-targeting subunit 1; Mypt; Mypt1; Ppp1r12a; Protein phosphatase 1 regulatory subunit 12A; protein phosphatase 1, regulatory (inhibitor) subunit 12A; protein phosphatase 1, regulatory subunit 12A",Ppp1r12a
"AU040756; Dar; DARP; DARPP-32; Darpp32; Dopamine- and cAMP-regulated neuronal phosphoprotein; OTTMUSP00000002442; Ppp1r1b; PPR1B; Protein phosphatase 1 regulatory subunit 1B; protein phosphatase 1, regulatory (inhibitor) subunit 1B; protein phosphatase 1, regulatory inhibitor subunit 1B",Ppp1r1b
"NEDLBA; PP2A-alpha; PP2AA; PP2Ac; PP2CA; PP2Calpha; PPP2CA; protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform; protein phosphatase 2 catalytic subunit alpha; protein phosphatase 2, catalytic subunit, alpha isoform; protein phosphatase 2, catalytic subunit, alpha isozyme; protein phosphatase 2A catalytic subunit, alpha isoform; Replication protein C; RP-C; serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform; Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform",PPP2CA
"Calcineurin subunit A beta; Calmodulin-dependent calcineurin A subunit beta isoform; Calna2; CAM-PRP catalytic subunit; PP2BB; Ppp3cb; protein phosphatase 3, catalytic subunit, beta isoform; Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform",Ppp3cb
"epididymis secretory sperm binding protein; PP-X; PP4; PP4C; PPH3; PPP4; PPP4C; PPX; protein phosphatase 4 (formerly X), catalytic subunit; protein phosphatase 4 catalytic subunit; protein phosphatase 4, catalytic subunit; Protein phosphatase X; protein phosphatase X, catalytic subunit; Serine/threonine-protein phosphatase 4 catalytic subunit",PPP4C
"ANP receptor; AU020526; OTTMUSP00000017740; PP5; PPP5; Ppp5c; PPT; protein phosphatase 5, catalytic subunit; Protein phosphatase T; Serine/threonine-protein phosphatase 5",Ppp5c
"FLJ92648; MGC12249; PP6; PP6C; PPP6; PPP6C; protein phosphatase 6 catalytic subunit; protein phosphatase 6, catalytic subunit; serine/threonine protein phosphatase catalytic subunit; Serine/threonine-protein phosphatase 6 catalytic subunit; Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed",PPP6C
"B-lymphocyte-induced maturation protein 1; Beta-interferon gene positive regulatory domain I-binding factor; beta-interferon gene positive-regulatory domain I binding factor; BLIMP-1; BLIMP1; MGC118922; MGC118923; MGC118924; MGC118925; Positive regulatory domain I-binding factor 1; PR domain 1; PR domain containing 1, with ZNF domain; PR domain zinc finger protein 1; PR domain-containing protein 1; PR-domain zinc finger protein 1; PR/SET domain 1; PRDI-BF1; PRDI-binding factor 1; PRDI-binding factor-1; PRDM1",PRDM1
"1300015D22Rik; 5'-AMP-activated protein kinase subunit beta-1; AAKB1; AMPK subunit beta-1; AMPKb; AMPKB1; AU021155; E430008F22; OTTMUSP00000015612; OTTMUSP00000015613; Prkab1; protein kinase, AMP-activated, beta 1 non-catalytic subunit",Prkab1
"cAMP-dependent protein kinase; cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase catalytic subunit C alpha 2; Cs; KAPCA; PKA; PKA C-alpha; Pkaca; PKCD; Prkaca; protein kinase A; protein kinase, cAMP dependent, catalytic, alpha; sperm cAMP-dependent protein kinase catalytic subunit",Prkaca
"A130035A12Rik; AW494342; KPCT; nPKC-theta; OTTMUSP00000012133; Pkc; PKC theta; PKC-; PKC-0; PKC-the; PKC-theta; Pkcq; PKCT; PKCthe; PKCtheta; Prkcq; Protein kinase C theta type; protein kinase C, theta",Prkcq
AD3L; AD3LP; AD4; AD5; Alzheimer disease 4; Alzheimer's disease 3-like; CMD1V; E5-1; presenilin 2; presenilin 2 (Alzheimer disease 4); Presenilin-2; Presenilin-2 CTF subunit; Presenilin-2 NTF subunit; PS-2; PS2; PSEN2; PSN2; PSNL2; STM-2; STM2,PSEN2
Fad; Fadk; FADK 1; Fak; FAK iso2; Fak1; Focal adhesion kinase 1; Focal adhesion kinase-related nonkinase; focal ashension kinase 1; FRNK; Kiaa4203; mKIAA4203; p125FAK; pp125FAK; Protein-tyrosine kinase 2; Ptk2; PTK2 protein tyrosine kinase 2,Ptk2
"protein tyrosine phosphatase 1B; protein tyrosine phosphatase non-receptor type 1; protein tyrosine phosphatase, non-receptor type 1; protein tyrosine phosphatase, placental; Protein-tyrosine phosphatase 1B; PTN1; PTP-1B; PTP1B; PTPN1; Tyrosine-protein phosphatase non-receptor type 1",PTPN1
"Neural-specific protein-tyrosine phosphatase; OTTMUSP00000017711; OTTMUSP00000017712; protein tyrosine phosphatase, non-receptor type 5; PTN5; Ptpn5; STEP; Striatum-enriched protein-tyrosine phosphatase; Tyrosine-protein phosphatase non-receptor type 5",Ptpn5
"HCP; HCPH; hematopoietic cell phosphatase; Hematopoietic cell protein-tyrosine phosphatase; HPTP1C; protein tyrosine phosphatase non-receptor type 6; protein tyrosine phosphatase, non-receptor type 6; Protein-tyrosine phosphatase 1C; Protein-tyrosine phosphatase SHP-1; PTN6; PTP-1C; PTP1C; PTPN6; SH-PTP1; SHP-1; SHP-1L; SHP1; Tyrosine-protein phosphatase non-receptor type 6",PTPN6
"70Z-SHP; Hcp; Hcph; Hematopoietic cell protein-tyrosine phosphatase; hemopoietic cell phosphatase; me; motheaten; protein tyrosine phosphatase, non-receptor type 6; Protein-tyrosine phosphatase 1C; PTN6; Ptp; PTP-1C; Ptp1C; Ptpn6; PTPTY-42; SH-PTP1; SH2 phosphatase 1; SHP; SHP-1; Tyrosine-protein phosphatase non-receptor type 6",Ptpn6
"BPTP-4; dual specificity phosphatase 1; Hematopoietic protein-tyrosine phosphatase; HEPTP; LC-PTP; LPTP; protein tyrosine phosphatase non-receptor type 7; protein tyrosine phosphatase, non-receptor type 7; Protein-tyrosine phosphatase LC-PTP; protein-tyrosine phosphatase, nonreceptor-type, stress induced; PTN7; PTPN7; PTPNI; Tyrosine-protein phosphatase non-receptor type 7",PTPN7
"HEPTP; HLPR; HPTPA; HPTPalpha; Leukocyte common antigen-related peptide (protein tyrosine phosphate); LRP; protein tyrosine phosphatase receptor type A; protein tyrosine phosphatase, receptor type, A; protein tyrosine phosphatase, receptor type, alpha polypeptide; Protein-tyrosine phosphatase alpha; PTPA; PTPase-alpha; PTPLCA-related phosphatase; PTPRA; PTPRL2; R-PTP-alpha; Receptor-type tyrosine-protein phosphatase alpha; RPTPA; tyrosine phosphatase alpha",PTPRA
CCYC; cell cycle checkpoint protein (RAD17); Cell cycle checkpoint protein RAD17; FLJ41520; hRad17; R24L; RAD1 homolog; RAD17; RAD17 checkpoint clamp loader component; RAD17 homolog; RAD17 homolog (S. pombe); Rad17-like protein; RAD17SP; RAD24; RF-C activator 1 homolog; RF-C/activator 1 homolog,RAD17
130 kDa retinoblastoma-associated protein; p13; p130; pRb2; RB transcriptional corepressor like 2; Rb-like 2; Rb2; Rbl2; RBR-2; retinoblastoma-like 2; Retinoblastoma-like protein 2; Retinoblastoma-related protein 2,Rbl2
AA516625; ESP10; RADI; Radixin; Rdx,Rdx
calcium/calmodulin-dependent protein kinase I; Camki; G alpha interacting protein; G-alpha-interacting protein; GAIP; MGC108699; Regulator of G-protein signaling 19; regulator of G-protein signalling 19; RGS19,Rgs19
"Aplysia ras-related homolog 12; ARH12; ARHA; EDFAOB; epididymis secretory sperm binding protein; h12; oncogene RHO H12; ras homolog family member A; ras homolog gene family, member A; Rho cDNA clone 12; RHO12; RHOA; RHOH12; small GTP binding protein RhoA; Transforming protein RhoA",RHOA
"aplysia ras-related homolog A; aplysia ras-related homolog A1; aplysia ras-related homolog A2; Arha; Arha1; Arha2; ras homolog A1; ras homolog A2; ras homolog family member A; ras homolog gene family, member A; ras homolog gene family, member A1; ras homolog gene family, member A2; Rho family GTPase; Rhoa; Transforming protein RhoA",Rhoa
"ARH9; ARHC; epididymis secretory sperm binding protein; h9; MGC1448; MGC61427; oncogene RHO H9; ras homolog family member C; ras homolog gene family, member C; RAS-related homolog 9; Rho cDNA clone 9; Rho-related GTP-binding protein RhoC; RHOC; rhoC GTPase; RHOH9; small GTP binding protein RhoC",RHOC
"BDB; BDB1; MGC163394; neurotrophic tyrosine kinase receptor-related 2; Neurotrophic tyrosine kinase, receptor-related 2; NTRKR2; receptor tyrosine kinase like orphan receptor 2; receptor tyrosine kinase-like orphan receptor 2; ROR2; Tyrosine-protein kinase transmembrane receptor ROR2",ROR2
40S ribosomal protein S6; MGC102571; MGC103209; OTTMUSP00000008183; Phosphoprotein NP33; ribosomal protein S6; Rps6; RS6; S6; S6R; Small ribosomal subunit protein eS6,Rps6
"90 kDa ribosomal protein S6 kinase 1; KS6A1; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAPK-1a; Mapkapk1a; OTTMUSP00000010160; p90-RSK 1; p90-Rsk1; p90rsk; p90RSK1; p90S6K; Ribosomal protein S6 kinase alpha-1; ribosomal protein S6 kinase polypeptide 1; Ribosomal protein S6 kinase, 90kD, 1; ribosomal protein S6 kinase, 90kD, polypeptide 1; Ribosomal S6 kinase 1; Rps6ka1; rsk; RSK-1; Rsk1; S6K-alpha-1",Rps6ka1
90 kDa ribosomal protein S6 kinase 1; KS6A1; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAPK-1a; Mapkapk1a; p90-RSK 1; p90RSK; p90RSK1; p90S6K; pp90RSK1; Ribosomal protein S6 kinase alpha-1; ribosomal protein S6 kinase polypeptide 1; Ribosomal S6 kinase 1; Rps6ka1; RSK-1; Rsk1; S6 protein kinase (Rsk-1); S6K-alpha 1; S6K-alpha-1,Rps6ka1
Oncogene RRAS; p23; R-Ras; ras family small GTP binding protein R-Ras; RAS related; Ras-related protein R-Ras; related RAS viral (r-ras) oncogene homolog; RRAS,RRAS
"4833414L08Rik; AA960457; CD362; fibro; Fibroglycan; heparan sulfate proteoglycan 1, cell surface-associated (fibroglycan); Heparan sulfate proteoglycan core protein; Hsp; HSPG; Hspg1; Sdc2; Syn; SYND2; syndecan 2; Syndecan-2",Sdc2
"CD362; cell surface-associated heparan sulfate proteoglycan 1; Fibroglycan; heparan sulfate proteoglycan 1, cell surface-associated; Heparan sulfate proteoglycan core protein; HSPG; HSPG1; SDC2; SYND2; syndecan 2; syndecan proteoglycan 2; Syndecan-2",SDC2
2510015P22Rik; A330005P07Rik; Cisk; Cytokine-independent survival kinase; fy; fz; serine/threonine protein kinase CISK; Serine/threonine-protein kinase Sgk3; serum/glucocorticoid regulated kinase 3; Serum/glucocorticoid-regulated kinase 3; Serum/glucocorticoid-regulated kinase-like; Sgk3; Sgkl,Sgk3
"Apoptosis regulatory protein Siva; CD27-binding (Siva) protein; CD27-binding protein; CD27BP; SIVA; Siva-1; Siva-2; SIVA1; SIVA1 apoptosis inducing factor; SIVA1, apoptosis-inducing factor",SIVA1
AI528653; Dwarfin-A; Dwf-A; Mad; MAD homolog 1; MAD homolog 1 (Drosophila); Mad-related protein 1; Mad1; Madh; Madh1; Madr1; Mlp1; mMad1; Mothers against decapentaplegic homolog 1; Mothers against DPP homolog 1; Mothers-against-DPP-related 1; MusMLP; OTTMUSP00000023243; SMAD 1; SMAD family member 1; Smad1,Smad1
AU022421; MAD homolog 3; MAD homolog 3 (Drosophila); Mad3; Madh; Madh3; mMad3; Mothers against decapentaplegic homolog 3; Mothers against DPP homolog 3; OTTMUSP00000023917; SMAD 3; SMAD family member 3; Smad3,Smad3
"DKFZp781C1895; DKFZp781O1323; Dwfc; hSmad5; JV5-1; MAD homolog 5; MAD, mothers against decapentaplegic homolog 5; MADH5; Mothers against decapentaplegic homolog 5; mothers against decapentaplegic, drosophila, homolog of, 5; Mothers against DPP homolog 5; SMA- and MAD-related protein 5; SMAD 5; SMAD family member 5; SMAD, mothers against DPP homolog 5; SMAD5",SMAD5
1110051M15Rik; AI451355; Dwarfin-C; Dwf-C; MAD homolog 5; MAD homolog 5 (Drosophila); Madh; Madh5; Mothers against decapentaplegic homolog 5; Mothers against DPP homolog 5; Msmad5; Mus; MusMLP; OTTMUSP00000022970; OTTMUSP00000022971; OTTMUSP00000022972; SMAD 5; SMAD family member 5; Smad5,Smad5
"25kDa; AA407989; AV026596; Biogenesis of lysosome-related organelles complex 1 subunit 7; Bloc; BLOC-1 subunit 7; Bloc1s7; OTTMUSP00000024888; Sna; SNAP-associated protein; Snap25bp; Snapap; Snapin; SNAPN; SNARE-associated protein Snapin; synaptosomal-associated protein 25 binding protein; Synaptosomal-associated protein 25-binding protein; synaptosomal-associated protein, 25 kDa, binding protein",Snapin
"Beta-synuclein; I(2)-synuclein; SNCB; synuclein beta; synuclein, beta; SYUB",SNCB
"-synuclein; BCSG1; Breast cancer-specific gene 1 protein; E pound-synuclein; Gamma-synuclein; PERSYN; PRSN; SNCG; SR; Synoretin; synuclein gamma; synuclein, gamma (breast cancer-specific protein 1); SYUG",SNCG
"C79089; Gamma-synuclein; Persyn; Sncg; synuclein, gamma; SYUG",Sncg
"Gamma-synuclein; Persyn; Sensory neuron synuclein; Sncg; synuclein, gamma (breast cancer-specific protein 1); SYUG",Sncg
c-fos serum response element-binding transcription factor; MCM1; minichromosome maintenance 1 homolog; Serum response factor; serum response factor (c-fos serum response element-binding transcription factor); SRF,SRF
2010005J02Rik; AA408197; Signal transducer and activator of transcription 1; Stat1,Stat1
Acute-phase response factor; ADMIO; ADMIO1; APRF; DNA-binding protein APRF; FLJ20882; HIES; MGC16063; Signal transducer and activator of transcription 3; signal transducer and activator of transcription 3 (acute-phase response factor); STAT3,STAT3
1110034C02Rik; acute phase response factor; Acute-phase response factor; Aprf; AW109958; OTTMUSP00000002052; OTTMUSP00000002053; Signal transducer and activator of transcription 3; Stat3,Stat3
Signal transducer and activator of transcription 4; signal transducer and activator of transcription 4 variant 3; SLEB11; STAT4,STAT4
Signal transducer and activator of transcription 4; Stat4,Stat4
epididymis secretory sperm binding protein; MGF; Signal transducer and activator of transcription 5A; STA5A; STAT5; STAT5A,STAT5A
GHISID2; Signal transducer and activator of transcription 5B; STA5B; STAT5; STAT5B; transcription factor STAT5B,STAT5B
mammary gland factor STAT5B; OTTMUSP00000002050; OTTMUSP00000002051; Signal transducer and activator of transcription 5B; STA5B; Stat5b,Stat5b
"D12S1644; IL-4 Stat; IL-4-STAT; Signal transducer and activator of transcription 6; signal transducer and activator of transcription 6, interleukin-4 induced; STAT, interleukin4-induced; STAT6; STAT6B; STAT6C; transcription factor IL-4 STAT",STAT6
AA408040; Liver kinase B1 homolog; Lkb; Lkb1; LKB1 short isoform; mLKB1; OTTMUSP00000020599; PAR-4; PAR4; R75140; serine/threonine kinase 11; Serine/threonine-protein kinase 11; Serine/threonine-protein kinase LKB1; Serine/threonine-protein kinase STK11; Stk11,Stk11
C1orf215; FLJ32206; Lag; LAP18; Leukemia-associated phosphoprotein p18; Metablastin; MGC138869; MGC138870; Oncoprotein 18; OP18; phosphoprotein 19; Phosphoprotein p19; pp17; pp19; PR22; Prosolin; Protein Pr22; SMN; Stathmin; stathmin 1; stathmin 1/oncoprotein 18; STMN1; testicular tissue protein Li 189; transmembrane protein C1orf215,STMN1
HPC-1; Neuron-specific antigen HPC-1; P35-1; STX1; STX1A; SYN1A; syntaxin 1A; syntaxin 1A (brain); Syntaxin-1A,STX1A
Syn1; synapsin 1; Synapsin I; Synapsin-1,Syn1
BOS_25913; brain protein 4.1; SYN-1; SYN1; synapsin I; Synapsin-1,SYN1
AA517024; Angiopoietin-1 receptor; Cd202b; Endothelial tyrosine kinase; endothelial-specific receptor tyrosine kinase; HYK; mTIE2; OTTMUSP00000008261; p140 TEK; RP23-345A23.1; STK1; Tek; TEK receptor tyrosine kinase; Tie; tie-; Tie-2; Tie2; Tunica interna endothelial cell kinase; Tyrosine kinase with Ig and EGF homology domains-2; Tyrosine-protein kinase receptor TEK; Tyrosine-protein kinase receptor TIE-2,Tek
FLJ41416; hTRF1-AS; NIMA-interacting protein 2; PIN2; t-TRF1; Telomeric protein Pin2/TRF1; telomeric repeat binding factor (NIMA-interacting) 1; telomeric repeat binding factor 1; telomeric repeat binding protein 1; Telomeric repeat-binding factor 1; TERF1; TRBF1; TRF; TRF1; TTAGGG repeat-binding factor 1,TERF1
Pin2; telomeric repeat binding factor 1; Telomeric repeat-binding factor 1; Terf1; Trbf; Trbf1; Trf; Trf1; TTAGGG repeat-binding factor 1,Terf1
"Alk; Alk-5; ALK5; AU017191; ESK2; OTTMUSP00000007205; Tbet; Tbeta; TbetaR-I; TbetaRI; TGF-beta receptor type I; TGF-beta receptor type-1; Tgfbr1; TGFR-1; TGFR1; transforming growth factor, beta receptor I; Transforming growth factor-beta receptor type I",Tgfbr1
"1110020H15Rik; AU042018; DNIIR; RIIDN; Tbet; Tbeta; TbetaR-II; TbetaRII; TBR; TBR-II; TGF-beta receptor II; TGF-beta receptor type II; TGF-beta receptor type-2; TGF-beta type II receptor; Tgfbr2; TGFR-2; TGFR2; transforming growth factor, beta receptor II; Transforming growth factor-beta receptor type II",Tgfbr2
Endopeptidase 24.15; EP24.15; MEPD_HUMAN; MP78; Thimet oligopeptidase; thimet oligopeptidase 1; THOP1; TOP,THOP1
Nafld; Tcs2; TSC complex subunit 2; Tsc2; tube; Tuberin; tuberous sclerosis 2; Tuberous sclerosis 2 protein homolog,Tsc2
0610006J14Rik; 40S ribosomal protein S27a; MCG13441; MCG15222; OTTMUSP00000005506; OTTMUSP00000005507; Polyubiquitin-B; Polyubiquitin-C; Ribosomal protein S27A; Rps27a; Uba52; Ubb; Ubc; UBIQ; ubiquitin; Ubiquitin-ribosomal protein eL40 fusion protein; Ubiquitin-ribosomal protein eS31 fusion protein,UBA52-RPS27A-UBB-UBC
40S ribosomal protein S27a; CEP80; Ribosomal protein S27a; RPS27A; UBA52; UBA80; UBB; UBC; UBCEP1; UBCEP80; UBIQ; ubiquitin; ubiquitin and ribosomal protein S27a; ubiquitin carboxyl extension protein 80; ubiquitin-CEP80; Ubiquitin-ribosomal protein eS31 fusion protein,UBA52-RPS27A-UBB-UBC
"2610301N02Rik; E2 ubiquitin-conjugating enzyme B; E2-14k; E214K; HR6; HR6B; mHR6B; OTTMUSP00000005786; OTTMUSP00000005787; Rad; RAD6 homolog B; Rad6b; Ube2b; Ubiquitin carrier protein B; Ubiquitin-conjugating enzyme E2 B; ubiquitin-conjugating enzyme E2B; ubiquitin-conjugating enzyme E2B, RAD6 homology; ubiquitin-conjugating enzyme E2B, RAD6 homology (S. cerevisiae); Ubiquitin-protein ligase B",Ube2b
"A930005G04Rik; NOR-90; Nucleolar transcription factor 1; OTTMUSP00000002630; OTTMUSP00000002631; OTTMUSP00000002632; OTTMUSP00000002633; Tcfubf; transcription factor UBF; UBF; UBF-1; Ubf1; Ubtf; upstream binding transcription factor, RNA polymerase I; Upstream-binding factor 1",Ubtf
p95vav; Proto-oncogene vav; Vav; vav 1 oncogene; vav oncogene; vav-T; Vav1,Vav1
Actin nucleation-promoting factor WAS; OTTMUSP00000019623; U42471; Was; WASp; Wiskott-Aldrich syndrome; Wiskott-Aldrich syndrome homolog; Wiskott-Aldrich syndrome homolog (human); Wiskott-Aldrich syndrome protein homolog,Was
